Physician
Pathology
Dr. Huamin Wang, MD
|
|
Give Review
Dr. Huamin Wang practices Pathology. He went to Tongji Medical University. Huamin Wang has written publications. He has 56 publications published with PubMed. The lastest paper is: 'Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The emerging roles of F-box proteins in pancreatic tumorigenesis.
- Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
- Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors.
- Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
- Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer.
- New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice.
- Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.
- Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
- Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype.
- Expression of Estrogen-Induced Genes and Estrogen Receptor β in Pancreatic Neuroendocrine Tumors: Implications for Targeted Therapy.
- Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
- Disrupted reproduction, estrous cycle, and circadian rhythms in female mice deficient in vasoactive intestinal Peptide.
- Hepatobiliary/Pancreas Pathology: SY11-3 PANCREATIC DUCTAL ADENOCARCINOMA: NEOADJUVANT THERAPIES AND PATHOLOGY.
- Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin Bound-Paclitaxel in Pancreatic Ductal Adenocarcinoma.
- Squamoid cystosis of pancreatic ducts: a variant of a newly-described cystic lesion, with evidence for an obstructive etiology.
- Cell surface lactate receptor GPR81 is crucial for cancer cell survival.
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer.
- Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.
- Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma.
- Real-time Human Pose and Shape Estimation for Virtual Try-On Using a Single Commodity Depth Camera.
- SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
- Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer.
- Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution.
- Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?
- The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1.
- Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenoca...
- Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
- Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival.
- Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer.
- PAF-Mediated MAPK Signaling Hyperactivation via LAMTOR3 Induces Pancreatic Tumorigenesis.
- Polymorphism in PGLYRP-1 gene by PCR-RFLP and its association with somatic cell score in Chinese Holstein.
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.
- A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice.
- A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth.
- Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.
- Anti-tumor activity and immunogenicity of a mutated staphylococcal enterotoxin C2.
- Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.
- Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells.
- Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
- Activation of Nuclear Factor-κB in Acinar Cells Increases the Severity of Pancreatitis in Mice.
- Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells.
- Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding ras and activating ras signaling.
- Overexpression of Protein Phosphatase 4 Correlates with Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma.
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.
- Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy.
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways.
- Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
- Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
- Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
- Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases.
- Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer.
- CSN6 drives carcinogenesis by positively regulating Myc stability.
- Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.
- SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium.
- Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis.
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
Tongji Medical University
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598851420 |
| Last Name Of The Provider | WANG |
| First Name Of The Provider | HUAMIN |
| View All |
Similar Doctors
|
|
Dr. Ekene I. Okoye, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah K. Galfione, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amin D. Alrahwan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Anzalone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zack R. Blailock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary M. Franco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lavinia P. Middleton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James R. Fletes, MD |
|
|
Dr. Youli Zu, MD
This Doctor is OpenDoctor Recommended.
|